PRECISION GENOME ENGINEERING, INC.

Basic Information

454 N 34TH ST
SEATTLE, WA, 98103-8602

Company Profile

n/a

Additional Details

Field Value
DUNS: 781229211
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Autologous HIV-1 resistant T cells through accelerated CCR5 gene disruption

    Amount: $1,358,027.00

    DESCRIPTION (provided by applicant): Treating patients infected with Human Immunodeficiency Virus-1 (HIV-1) is a substantial clinical challenge with evolving pharmaceutical drug and dosing options. Tr ...

    STTR Phase II 2013 Department of Health and Human Services
  2. Modular custom nuclease platform for genome engineering therapies

    Amount: $297,980.00

    DESCRIPTION (provided by applicant): Genome engineering is an emerging field in which genomic DNA sequences are modified for biotechnological and therapeutic purposes. Highly specific endonucleases ar ...

    SBIR Phase I 2012 Department of Health and Human Services
  3. Engineered Nuclease for Glucocorticoid Receptor Gene Editing

    Amount: $174,053.00

    DESCRIPTION (provided by applicant): Genome engineering is an emerging field in which targeted genome modifications are made for biotechnological and therapeutic applications. Site specific rare c ...

    SBIR Phase I 2010 Department of Health and Human Services
  4. Engineered nuclease for CCR5 gene editing

    Amount: $101,156.00

    DESCRIPTION (provided by applicant): State the application's broad, long-term objectives and specific aims, making reference to the health relatedness of the project (i.e., relevance to the mission of ...

    STTR Phase I 2009 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government